The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Minocycline for acne vulgaris: efficacy and safety
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2012
|
| DOI | 10.1002/14651858.cd002086.pub2 |
| Pubmed ID | |
| Authors |
Sarah E Garner, Anne Eady, Cathy Bennett, John Norman Newton, Karen Thomas, Catalin Mihai Popescu |
| Abstract |
Minocycline is an oral antibiotic used for acne vulgaris. Its use has lessened due to safety concerns (including potentially irreversible pigmentation), a relatively high cost, and no evidence of any greater benefit than other acne treatments. A modified-release version of minocycline is being promoted as having fewer side-effects. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 9% |
| France | 2 | 6% |
| China | 1 | 3% |
| Mexico | 1 | 3% |
| Unknown | 25 | 78% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 50% |
| Practitioners (doctors, other healthcare professionals) | 6 | 19% |
| Scientists | 1 | 3% |
| Unknown | 9 | 28% |
Mendeley readers
The data shown below were compiled from readership statistics for 443 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Germany | 1 | <1% |
| Ireland | 1 | <1% |
| Chile | 1 | <1% |
| Peru | 1 | <1% |
| Qatar | 1 | <1% |
| Unknown | 436 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 58 | 13% |
| Researcher | 55 | 12% |
| Student > Bachelor | 45 | 10% |
| Student > Ph. D. Student | 41 | 9% |
| Student > Postgraduate | 31 | 7% |
| Other | 78 | 18% |
| Unknown | 135 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 155 | 35% |
| Nursing and Health Professions | 33 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 5% |
| Agricultural and Biological Sciences | 15 | 3% |
| Psychology | 15 | 3% |
| Other | 57 | 13% |
| Unknown | 146 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2024.
All research outputs
#1,515,518
of 26,385,174 outputs
Outputs from Cochrane database of systematic reviews
#3,045
of 13,215 outputs
Outputs of similar age
#8,665
of 188,165 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 211 outputs
Altmetric has tracked 26,385,174 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,215 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,165 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 211 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.